Applying proprietary predictive technologies to accelerate drug development and advance toward predicting the proteome for any protein–HLA combination.
Joined April 2024
- Tweets 31
- Following 3
- Followers 42
- Likes 37
2 Photos and videos
Jun 10
RT @DrRyanSaadi: The most powerful pharmacy in the world isn’t on a street corner. It’s already inside our veins. @TevogenBio - #Tcell
🌐 h…
5
Jun 9
RT @TevogenBio: 📰 globenewswire.com/news-relea…
“Tevogen’s evaluation of potential MSO and CRO acquisitions reflects a disciplined approach to b…
4
Jun 8
RT @TevogenBio: “Bridging medical science and artificial intelligence to develop affordable, lifesaving therapies isn’t just innovation, it…
3
Jun 5
RT @TevogenBio: At JPM43 Mittul Mehta, @Head_TevogenAI and @drhew
Chief Medical Officer & VP of Healthcare at
@Microsoft discussed AI in Bi…
4
Apr 27
RT @TevogenBio: 📰 globenewswire.com/news-relea…
“Advancing PredicTcell toward completion marks an important milestone in our AI strategy,” said…
4
Mar 27
RT @TevogenBio: 🔗 databricks.com/blog/tevogen-…
As part of our ongoing work on PredicTcell™, we’ve been leveraging scalable data infrastructure…
4
Mar 19
RT @TevogenBio: Tevogen.AI at @FABConSQLCon
Tevogen CIO and @Head_TevogenAI, Mittul Mehta, speaking to building an AI-ready d…
3
Tevogen AI retweeted
Mar 18
Honored to see Tevogen.AI recognized by @Microsoft at #FabCon as an ISV. AI in biotech is shifting from models to systems—continuous learning, real-world feedback, and scale. Just getting started. #AI #Biotech $TVGN $MSFT @arunulag
4
4
459
Mar 13
RT @TevogenBio: 📰 globenewswire.com/news-relea…
@Head_TevogenAI Mittul Mehta, stated, “Our goal is to reduce trial-and-error in immunotherapy de…
3
Tevogen AI retweeted
Mar 10
"What are you actually seeing from PredicTcell?" Early beta: Recall up to 92%, Precision to 48%, true positives rising. Built on 665M peptides, solving a real gap in precision immunotherapy. Preliminary results, but I'm comfortable sharing them. $TVGN #Biotech #AI
4
6
353
Feb 26
RT @Tevogen: 📰 globenewswire.com/news-relea…
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care…
4
Feb 20
RT @TevogenBio: 📢 From Mittul Mehta, Tevogen CIO and @Head_TevogenAI.
Most companies celebrate going public. We used it as a starting gun.…
3
Jan 29
RT @TevogenBio: 📰 globenewswire.com/news-relea…
“Tevogen began as a T cell therapy biotech and has since evolved into a diversified healthcare c…
3
Jan 29
RT @TevogenBio: 📢 From Mittul Mehta, Tevogen CIO and Head of @TevogenAI
Reflecting on the past year at Tevogen.AI, I’m proud…
5
Jan 14
RT @TevogenBio: 🎙Q&A with Tevogen CEO🎙
Q. As Tevogen continues to build long-term value, how do you think about capital allocation and sha…
3
Jan 12
RT @TevogenBio: 📰 globenewswire.com/news-relea…
🔹Platform & Manufacturing Progress: Advanced the ExacTcell™ platform in 2025, improving CTL yiel…
5
Jan 5
RT @Tevogen: Meet Tevogen leadership at the 44th Annual J.P. Morgan Healthcare Conference taking place in San Francisco, CA from January 12…
6
9 Dec 2025
RT @TevogenBio: “Dr. Patton’s leadership and scientific vision have played a pivotal role in shaping Tevogen’s foundation,” said @DrRyanSaa…
3
26 Nov 2025
RT @TevogenBio: 🍂 As we approach Thanksgiving, we cannot think of a better time to express our immense gratitude to each of you for embraci…
4
19 Nov 2025
RT @CEO_TEVOGEN_BIO: American patients have waited long enough. America needed a healthcare enterprise that didn’t require billions. They s…
5